24-hour intraocular pressure monitoring: opportunities and challenges
https://doi.org/10.25700/NJG.2018.03.09
Abstract
This review summarizes the concept and value of diurnal and 24-h intraocular pressure (IOP) monitoring and its role in the management of glaucoma. The IOP in healthy persons and glaucoma patients is generally evaluated in single/double IOP measurement during clinic hours, although IOP varies over the course of 24 hours. However, in many cases, the IOP peaks outside clinic hours. Several studies documented the association between IOP peaks and visual field decline in primary open angle glaucoma patients, but the role of IOP fluctuations is still debated.
Current and future technologies for measuring IOP over a 24-h period are discussed and available evidence on the 24-h efficacy of medical, laser and surgical strategies for glaucoma treatment is evaluated. Several controlled trials have significantly enhanced our understanding of the 24-h efficacy of various glaucoma therapy options and have shown that glaucoma therapies differ in their ability to lower IOP throughout the 24-h cycle.
More long-term evidence is needed to better evaluate the 24-h efficacy of glaucoma therapy and the influence of IOP parameters on glaucoma progression and visual prognosis.
About the Authors
A. Y. Brezhnev
Kursk State Medical University.
Russian Federation
Russian Federation
Ph.D., Associate Professor, Ophthalmology Department.
3 Karl Marx st., Kursk, Russian Federation, 305041.
V. I. Baranov
Kursk State Medical University.
Russian Federation
Russian Federation
Med.Sc.D., Professor, Head of the Ophthalmology Department.
3 Karl Marx st., Kursk, Russian Federation, 305041.
A. V. Kuroyedov
Mandryka Military Clinical Hospital; Pirogov State National Medical University, Ophthalmology Department.
Russian Federation
Russian Federation
Med.Sc.D., Professor, Head of the Ophthalmology Department.
8A Bolshaya Olenya st., Moscow, Russian Federation, 107014.
1 Ostrovityanova st., Moscow, Russian Federation, 117997.
S. Yu. Petrov
Glaucoma Department of the Scientific Research Institute of Eye Diseases.
Russian Federation
Russian Federation
Ph.D., Leading research associate.
11a Rossolimo st., Moscow, Russian Federation, 119021.
A. A. Antonov
Glaucoma Department of the Scientific Research Institute of Eye Diseases.
Russian Federation
Russian Federation
Ph.D., Leading research associate.
11a Rossolimo st., Moscow, Russian Federation, 119021.
References
1. Kass M.A., Heuer D.K., Higginbotham E.J. et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):701-713. doi: 10.1001/archopht.120.6.701.
2. Garway-Heath D.F., Lascaratos G., Bunce C. et al. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology. Ophthalmology. 2013; 120(1):68-76. doi: 10.1016/j.ophtha.2012.07.028.
3. Heijl A., Leske M.C., Bengtsson B. et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120(10):1268-1279. doi: 10.1001/archopht.120.10.1268.
4. Musch D.C., Gillespie B.W., Niziol L.M. et al. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011; 118(9):1766-1773. doi: 10.1016/j.ophtha.2011.01.047.
5. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000; 130(4):429-440. doi: 10.1016/S0002-9394(00)00538-9.
6. Alexeev V.N., Egorov E.A., Martynova E.B. Intraocular pressure levels distribution in normal population. RMJ. Clin Ophthalmol. (Russia). 2001; 2:38–40. (In Russ.).
7. Bergea B., Bodin L., Svedbergh B. Impact of intraocular pressure regulation on visual fields in open angle glaucoma. Ophthalmology. 1999; 106(5):997-1004. doi: 10.1016/S0161-6420(99)00523-0.
8. Asrani S., Zeimer R., Wilensky J. et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000; 9(2):134-142. doi: 10.1097/00061198-200004000-00002.
9. Realini T., Barber L., Burton D. Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology. 2002; 109(7):1367-1371. doi: 10.1016/s0161-6420(02)01073-4.
10. Buckingham T., Young R. The rise and fall of intra-ocular pressure: the influence of physiological factors. Ophthalmic Physiol Opt. 1986; 6(1):95-9. doi: 10.1016/0275-5408(86)90125-0.
11. Sit A.J. Continuous monitoring of intraocular pressure: rationale and progress toward a clinical device. J Glaucoma. 2009; 18(4):272–279. doi: 10.1097/IJG.0b013e3181862490.
12. Orzalesi N., Rossetti .L, Invernizzi T. et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci. 2000; 41(9):2566–2573. doi: 10.1016/s0002-9394(00)00751-0.
13. Barkana Y., Anis S., Liebmann J. et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch. Ophthalmol. 2006; 124(6):793-797. doi: 10.1001/archopht.124.6.793.
14. Hattenhauer M.G., Johnson D.H., Ing H.H. et al. The probability of blindness from open-angle glaucoma. Ophthalmology. 1998; 105(11):2099–2104. doi: 10.1016/S0161-6420(98)91133-2.
15. Liu J.H., Zhang X., Kripke D.F. et al. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003; 44(4):1586–1590. doi: org/10.1167/iovs.02-0666.
16. Liu J.H., Medeiros F.A., Slight J.R., Weinreb R.N. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology. 2010; 117(11):2075-209. doi: 10.1016/j.ophtha.2010.03.026.
17. Sugar S.H. The glaucomas, 2nd Edition. New York: Hoeber; 1957:261.
18. Pointer J.S. The diurnal variation of intraocular pressure in non-glaucomatous subjects: relevance in a clinical context. Ophthalmic Physiol Opt. 1997; 17(6):456-465. doi: 10.1046/j.1475-1313.1997.97000367.x.
19. Thiel R. Die physiologischen und experimentell erzeugten Schwankungen des intraokularen Druckes im gesunden und glaukomatosen Auge. Arch Augenheilk. 1925; 96:331-354.
20. Leydhecker W., Meinke A. Should the ocular tension of glaucoma patients be taken in the morning before or after arising? Am. J Ophthalmol. 1956; 43:176.
21. Abysheva L.D., Avdeev R.V., Alexandrov A.S. et al. Multicenter study of intraocular pressure level in patients with moderate and advanced primary open-angle glaucoma on treatment. Oftalmologicheskie vedomosti 2015; 1:52-69. (In Russ.).
22. Ustinova E.I. Metody rannei diagnostiki glaukomy [Methods of early glaucoma diagnosis]. Moscow: Medicine; 1966: 68. (In Russ.).
23. Mansouri K., Weinreb R.N., Medeiros F.A. Is 24-hour intraocular pressure monitoring necessary in glaucoma? Semin. Ophthalmol. 2013; 28(3):157–164. doi: 10.3109/08820538.2013.771201.
24. Sit A.J., Nau C.B., McLaren J.W. et al. Circadian variation of aqueous dynamics in young healthy adults. Invest Ophthalmol Vis Sci. 2008; 49(4):1473-1479. doi: 10.1167/iovs.07-1139.
25. Liu J.H., Kripke D.F., Twa M.D. et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999; 40(12):2912-2917.
26. Konstas A., Maiziris D.A., Stewart W.C. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997; 115(2):182-185. doi: 10.1001/archopht.1997.01100150184006.
27. Konstas A.G., Tsatsos I., Kardasopoulos A. et al. Preoperative fea tures of patients with exfoliation glaucoma and primary open angle glaucoma. Acta Ophthalmol Scand. 1998;76(2):208-212. doi: 10.1034/j.1600-0420.1998.760217.x.
28. Brezhnev A.Yu., Kurysheva N.I., Trubilin V.N., Baranov V.I. Prob lems of early clinical diagnostics of pseudoexfoliation syndrome. Ophthalmology. 2012; 9(1):49-52. (In Russ.).
29. Baranov V.I., Brezhnev A.Yu. Pseudoexfoliation syndrome in Central Russia: clinicalepidemiological study. Russian J. Ophthalmol. 2012; 5(1):22–24. (In Russ.).
30. Hollo G., Konstas A. Exfoliation Syndrome and Exfoliative Glaucoma. EGS, 2008:161.
31. Brezhnev A.Yu., Baranov V.I., Petrov S.Yu. Pseudoexfoliation syn drome as a risk factor for dry eye. RMJ. Clinical ophthalmology. 2016;16(1):30–34. (In Russ.).
32. Konstas A.G., Hollo G., Astakhov Y.S. et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004; 122(1):29-33. doi: 10.1001/archopht.122.1.29.
33. Caprioli J., Coleman A.L. Intraocular pressure fluctuation a risk fac tor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008; 115(7):1123–1129.e3. doi: 10.1016/j.ophtha.2007.10.031.
34. Quaranta L., Katsanos A., Russo A., Riva I. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013; 58(1):26–41. doi: 10.1016/j.survophthal.2012.05.003.
35. O’Brien C., Schwartz B., Takamoto T., Wu D.C. Intraocular pres sure and the rate of visual field loss in chronic open-angle glauco ma. Am J Ophthalmol. 1991; 111(4):491-500. doi: 10.1016/s0002-9394(14)72386-4.
36. Stewart W.C., Kolker A.E., Sharpe E.D. et al. Factors associated with long-term progression or stability in primary open-angle glauco ma. Am J Ophthalmol. 2000; 130(3):274-279. doi: 10.1016/s0002-9394(00)00487-6.
37. Nouri-Mahdavi K., Hoffman D., Coleman A.L. et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004; 111(9):1627-1635. doi: 10.1016/j.ophtha.2004.02.017.
38. Daugeliene L., Yamamoto T., Kitazawa Y. Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol. 1999; 237(2):105-108. doi: 10.1007/s004170050203.
39. Gonzalez I., Pablo I.E., Pueyo M. et al. Assessment of diurnal tension curve in early glaucoma damage. Int Ophthalmol. 1997; 20:113–115. doi: 10. 1007/bf00212956.
40. Bengtsson B., Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hyper tension. Graefes Arch Clin Exp Ophthalmol. 2005; 243(6):513-518. doi: 10.1007/s00417-004-1103-8.
41. Smith J. Diurnal intraocular pressure. Correlation to automated perimetry. Ophthalmology. 1985; 92(7):858-861. doi: 10.1016/s0161-6420(85)33926-x.
42. Astakhov Yu.S., Ustinova E.I., Katinas G.S. et al. On traditional and modern methods of ophthalmotonus fluctuations investigation. Oftalmologičeskie vedomosti. 2008; 1(2):7-12. (In Russ.).
43. Morledge-Hampton S.J., Kwon R.O., Krishna R. et al. Comparison of Proview phosphene tonometry with Goldmann applanation tonome try. Can J Ophthalmol. 2006; 41(6):722-726. doi: 10.3129/i06-065.
44. Liang S.Y., Lee G.A., Shields D. Self-tonometry in glaucoma manage ment — past, present and future. Surv Ophthalmol. 2009; 54(4):450-462. doi: 10.1016/j.survophthal.2009.04.006.
45. Witte V., Glass A., Beck R. et al. Evaluation of the self-tonome ter Icare ONE in comparison to Goldmann applanation tonometry. Ophthalmologe. 2012; 109(10):1008-1013. doi: 10.1007/s00347-012-2526-y.
46. Mansouri K., Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma. Br J Ophthalmol. 2011; 95(5):627-629. doi: 10.1136/bjo.2010.192922.
47. Tojo N., Hayashi A., Otsuka M., Miyakoshi A. Fluctuations of the intraocular pressure in pseudoexfoliation syndrome and normal eyes measured by a contact lens sensor. J Glaucoma. 2016; 25(5):e463–e468. doi: 10.1097/IJG.0000000000000292.
48. Mansouri K., Medeiros F.A., Tafreshi A., Weinreb R.N. Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma. Arch Ophthalmol. 2012; 130(12):1534–1539. doi: 10.1001/jamaophthalmol.2013.1350.
49. Agnifili L., Mastropasqua R., Frezzotti P. et al. Circadian intraocular pressure patterns in healthy subjects, primary open angle and normal tension glaucoma patients with a contact lens sensor. Acta Ophthalmol. 2015; 93(1):e14–e21. doi: 10.1111/aos.12408.
50. Tojo N., Abe S., Ishida M. et al. The fluctuation of intraocular pressure measured by a contact lens sensor in normal-tension glaucoma patients and nonglaucoma subjects. J Glaucoma. 2017; 26(3):195–200. doi: 10.1097/IJG.0000000000000517.
51. Tan S., Yu M., Baig N. et al. Circadian intraocular pressure fluctuation and disease progression in primary angle closure glaucoma. Invest Ophthalmol Vis Sci. 2015; 56(8):4994–5005. doi: 10.1167/iovs.15-17245.
52. Cheng J., Kong X., Xiao M., Sun X. Twenty-four-hour pattern of intraocular pressure in untreated patients with primary open-angle glaucoma. Acta Ophthalmol. 2016; 94(6):e460-7. doi: 10.1111/aos.12963.
53. Parekh A.S., Mansouri K., Weinreb R.N. et al. Twenty-four-hour intraocular pressure patterns in patients with thyroid eye disease. Clin Exp Ophthalmol. 2015; 43(2):108–114. doi: 10.1111/ceo.12400.
54. Holló G., Kóthy P., Vargha P. Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma. J Glaucoma. 2014; 23(1):e6–e12. doi: 10.1097/IJG.0b013e31829e5635.
55. Pajic B., Pajic-Eggspuchler B., Haefliger I. Continuous IOP fluctuation recording in normal tension glaucoma patients. Curr Eye Res. 2011; 36(12):1129–1138. doi: 10.3109/02713683.2011.608240.
56. Mansouri K., Medeiros F.A., Weinreb R.N. Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor. Clin Exp Ophthalmol. 2015; 43(9):787-795. doi: 10.1111/ceo.12567.
57. De Moraes C.G., Jasien J.V., Simon-Zoula S. et al. Visual field change and 24-hour IOP-related profile with a Contact Lens Sensor in treated glaucoma patients. Ophthalmology. 2016; 123(4):744–753. doi: 10.1016/j.ophtha.2015.11.020.
58. Lee J.W., Fu L., Chan J.C., Lai J.S. Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2014; 93(27):e238. doi: 10.1097/MD.0000000000000238.
59. Tojo N., Oka M., Miyakoshi A. et al. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. J Glaucoma. 2014; 23(8):e138–e143. doi: 10.1097/IJG.0000000000000026.
60. Rekas M., Danielewska M.E., Byszewska A. et al. Assessing efficacy of canaloplasty using continuous 24-hour monitoring of ocular dimensional changes. Invest Ophthalmol Vis Sci. 2016; 57(6):2533–2542. doi: 10.1167/iovs.16-19185.
61. Osorio-Alayo V., Pérez-Torregrosa V.T., Clemente-Tomás R. et al. Efficacy of the SENSIMED Triggerfish® in the postoperative follow-up of PHACO-ExPRESS combined surgery. Arch Soc Esp Oftalmol. 2017; 92(8):372-378. doi: 10.1016/j.oftal.2017.04.003.
62. Kuroyedov A.V., Brezhnev A.Yu., Egorov E.A. et al. New characteristics of IOP level in primary open-angle glaucoma patients before and after surgery on the background of round-the-clock monitoring with the use of modern technology (pilot study) // RMJ. Clinical оphthalmology. 2016; 17(2):65-74. (In Russ.). doi: 10.21689/2311-7729-2016-16-2-65-74.
63. Mottet B., Aptel F., Romanet J.P. et al. 24-hour intraocular pressure rhythm in young healthy subjects evaluated with continuous monitoring using a contact lens sensor. JAMA Ophthalmol. 2013; 131(12):1507–1516. doi: 10.1001/jamaophthalmol.2013.5297.
64. Ittoop S.M., SooHoo J.R., Seibold L.K. et al. Systematic review of current devices for 24-h intraocular pressure monitoring. Adv Ther. 2016; 33(10): 1679–1690. doi: 10.1007/s12325-016-0388-4.
65. Koutsonas A., Walter P., Roessler G., Plange N. Implantation of a novel telemetric intraocular pressure sensor in patients with glaucoma (ARGOS study): 1-year results. Invest Ophthalmol Vis Sci. 2015; 56(2):1063–1069. doi: 10.1167/iovs.14-14925.
66. Varel C., Shih Y-C., Otis B.P. et al. A wireless intraocular pressure monitoring device with a solder-filled microchannel antenna. J Micromech Microeng. 2014; 24(4):045012. doi: 10.1088/0960-1317/ 24/4/045012.
Review
For citations:
Brezhnev A.Y., Baranov V.I., Kuroyedov A.V., Petrov S.Yu., Antonov A.A. 24-hour intraocular pressure monitoring: opportunities and challenges. National Journal glaucoma. 2018;17(3):77-85. (In Russ.) https://doi.org/10.25700/NJG.2018.03.09
Views:
1082
Email this article 